Eli Lilly-Manufacturing Expansion
![Eli Lilly-Manufacturing Expansion](/upload/6926996/d82c6808b97446be80c2d99e27d00001--0--b068bcfc14484ef797062cacfcc06d82.jpg?w=1000&original=)
Eli Lilly-Manufacturing Expansion
FILE - A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro. The drugmaker said Friday, May 24, 2024 that it was more than doubling its investment in a site near its Indianapolis headquarters. (AP Photo/Darron Cummings, File)
Абонирайте се
Влезте във Вашата БТА
Избиране на снимки
Моля потвърдете избраните снимки. Това действие не е свързано с плащане. Ако продължите, избраните снимки ще бъдат извадени от баланса на вашите активни абонаментни пакети.
Изтегляне на снимка
Моля потвърдете изтеглянето на снимката/ите
![Eli Lilly-Manufacturing Expansion](/upload/6926996/d82c6808b97446be80c2d99e27d00001--0--b068bcfc14484ef797062cacfcc06d82.jpg?w=270&h=180)
FILE - A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro. The drugmaker said Friday, May 24, 2024 that it was more than doubling its investment in a site near its Indianapolis headquarters. (AP Photo/Darron Cummings, File)